Electronic Tuning Fork (ETF)
Patented 128 Hz Frequency
Diabetes & Large Fiber Neuropathy
The Electronic Tuning Fork™ (ETF) is an FDA Registered Wireless Tool with U.S. Patents on the 128 Hz Frequencies that Objectively Identify Large Nerve Fibers in Peripheral Extremities, Quickly and Painlessly.
The ETF is the only patented 128 Hz frequency that can objectively identify and measure large fiber neuropathy.
Early-Stage DPN Diagnosis
The 128 Hz frequency is the recognized standard in the U.S. for testing peripheral neuropathy, particularly for evaluating vibration perception in large fiber nerve function. Widely endorsed by organizations such as the American Diabetes Association (ADA), CDC. and CMS guidelines, this trusted method forms the foundation for the Electronic Tuning Fork™ (ETF), which enhances and modernizes vibration testing with electronic precision.
The ETF™ is a patented, FDA-registered medical device designed by an American Foot and Ankle Surgeon. It preserves the accuracy and reliability clinicians rely on while overcoming the limitations of traditional tuning forks. By providing objectivity, standardization, and quantifiable results, the ETF™ offers a cutting-edge solution for diagnosing and monitoring neuropathy progression, empowering physicians with advanced tools to improve patient outcomes.
Diabetic Large Nerve Fiber Dysfunction (Painless) as Measured by Vibration Predicts Foot Ulceration, Amputation and Mortality.
https://care.diabetesjournals.org/content/32/10/1896
The only patented large fiber neuropathy tool in the market to deliver 128 Hz frequency.
About ETF 128 Hz
Measures large fiber nerves to stimuli at 128Hz
Wireless
Non-invasive
1-minute test
Portable (fits in pocket)
No disposables needed
Delivers quantitative documentation for EMRs
Five (5) vibration amplitude modes available: Descending, Ascending, Constant, Fx Test and Vibroception Average
Why the ETF Matters
Diabetic Peripheral Neuropathy (DPN) is a significant risk factor for diabetic limb loss, often progressing to foot ulcers and lower-extremity amputations if left undiagnosed or untreated. These complications are linked to high mortality rates. While traditional 128 Hz tuning forks have been an invaluable tool for detecting DPN, they lack standardization and the ability to provide measurable results.
The ETF™ overcomes these challenges by offering:
Objectivity: Eliminates variability in manual testing.
Standardization: Ensures consistent testing protocols across patients and providers.
Quantification: Provides measurable data for documenting clinical findings in electronic medical records (EMRs).
The ETF™ allows clinicians to diagnose DPN earlier, enabling the implementation of preventive strategies to reduce limb loss and improve patient outcomes. Its improved accuracy, reproducibility, and ability to provide objective data make it an indispensable tool for modern neurological screening. With the ETF™, physicians can confidently take the next step in patient care, combining the sensitivity of traditional tuning forks with the precision and standardization of cutting-edge technology.
ETF 128 Hz Measurement
Patient Report
Simply Better
